(Q35062094)

6 August 2017

1 reference

title

Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis (English)

1 reference

biodegradable microsphere

6 August 2017

0 references

1 reference

1 reference

1 reference

6

Tsutomu Chiba

1 reference

6 August 2017

4

Yasuhiko Tabata

1 reference

6 August 2017

Kazuichi Okazaki

1

1 reference

6 August 2017

Hiroshi Nakase

series ordinal

2

1 reference

6 August 2017

Norihiko Watanabe

series ordinal

3

1 reference

6 August 2017

Yoshito Ikada

series ordinal

5

1 reference

6 August 2017

1 November 2002

1 reference

Journal of Gastroenterology

6 August 2017

1 reference

6 August 2017

37 Suppl 14

1 reference

6 August 2017

44-52

1 reference

Inflammatory bowel disease (1)

6 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Inflammatory bowel disease (2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03326413

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

12 December 2020

Alterations of the immune system in ulcerative colitis and Crohn's disease.

1 reference

12 December 2020

Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease

1 reference

12 December 2020

Severe colitis in mice with aberrant thymic selection

1 reference

12 December 2020

Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy

1 reference

12 December 2020

Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice

1 reference

12 December 2020

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.

1 reference

12 December 2020

An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.

1 reference

12 December 2020

Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice

1 reference

12 December 2020

Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease

1 reference

12 December 2020

Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease

1 reference

12 December 2020

New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease

1 reference

12 December 2020

Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases

1 reference

12 December 2020

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

12 December 2020

Hapten-induced model of chronic inflammation and ulceration in the rat colon

1 reference

12 December 2020

Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development

1 reference

12 December 2020

Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.

1 reference

12 December 2020

Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03326413

1 reference

6 August 2017

1 reference